🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchBimagrumab + semaglutide — my results so far Page 5

Bimagrumab + semaglutide — my results so far

MaxMetOK Fri, Jan 9, 2026 at 3:38 PM 32 replies 1,200 viewsPage 5 of 7
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Jan 11, 2026 at 7:58 PM#21
TrialTracker_MD said:
Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

Last edited: Jan 12, 2026 at 1:58 AM
18 16jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 15 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Jan 12, 2026 at 5:03 AM#22
TrialTracker_MD said:
Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak.

Genuinely useful, thank you. I had the facts and not the framework. I will report back once I have actually tried it.

19 17JenPlateau, SallyK_inj, CryptoCarl and 16 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jan 12, 2026 at 2:08 PM#23

From the other side of the consultation, briefly. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

20 18jennifer_SEA, tyler_CSCS, VanRx_Mike and 17 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
Jan 12, 2026 at 11:13 PM#24
Dr.GutHealth said:
The version of this that has an answer is narrower than the version being asked.

Second this.

Last edited: Jan 13, 2026 at 12:13 AM
21 19TrialTracker_MD, JennaRN, LabKate and 18 others
Reply Quote Save Share Report
FranDenver
Member
267
1,123
Oct 2024
Denver, CO
Jan 13, 2026 at 8:18 AM#25
Dr.GutHealth said:
The version of this that has an answer is narrower than the version being asked.

Coming at Dr.GutHealth’s question from a different direction. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

22 20GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 19 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register